Home › Funds › LUMINUS MANAGEMENT LLC › CNTX

LUMINUS MANAGEMENT LLC position in CNTX

CONTEXT THERAPEUTICS INC · Health Care

LUMINUS MANAGEMENT LLC reported holding 913,715 shares of CNTX (CONTEXT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$274K, representing 0.18% of its reported portfolio and ranking #25 among its reported holdings. LUMINUS MANAGEMENT LLC has disclosed CNTX holdings in 2 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)913.72K sh
Reported value held$274.48K
Portfolio Weight0.18%
First reportedQ2 2025
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How LUMINUS MANAGEMENT LLC's CNTX position evolved

LUMINUS MANAGEMENT LLC first disclosed a stake in CNTX in Q2 2025 at 328,222 shares (US$215K). The position peaked in Q3 2026 at 913,715 shares, worth US$274K. Across 2 filings, LUMINUS MANAGEMENT LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 913,715 shares valued at US$274K.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 328.22K $215.05K New
Q3 2026 913.72K $274.48K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CNTX and 13F data

CNTX (CONTEXT THERAPEUTICS INC) is a Health Care company. 26 other funds we track also report a position in CNTX — the largest reported positions include Nextech Invest Ltd. (US$2.2M), Avidity Partners Management LP (US$1.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CNTX

All CNTX fund holders →

FAQ

How long has LUMINUS MANAGEMENT LLC held CNTX?

LUMINUS MANAGEMENT LLC has disclosed CNTX holdings in 2 of the last 6 reported quarters, going back to Q2 2025.

What is LUMINUS MANAGEMENT LLC's current position in CNTX?

As of Q3 2026, LUMINUS MANAGEMENT LLC holds 913.72K shares of CNTX (CONTEXT THERAPEUTICS INC), valued at $274.48K, representing 0.18% of its reported portfolio and ranking #25.

Has LUMINUS MANAGEMENT LLC been buying or selling CNTX?

In the latest 13F filing (Q3 2026), LUMINUS MANAGEMENT LLC newly opened its position in CNTX. The position peaked in Q3 2026 at 913.72K shares.

Which other funds hold CNTX?

Other major institutional holders of CNTX include Nextech Invest Ltd., Avidity Partners Management LP, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.